1. Home
  2. AOSL vs STOK Comparison

AOSL vs STOK Comparison

Compare AOSL & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AOSL
  • STOK
  • Stock Information
  • Founded
  • AOSL 2000
  • STOK 2014
  • Country
  • AOSL United States
  • STOK United States
  • Employees
  • AOSL N/A
  • STOK N/A
  • Industry
  • AOSL Semiconductors
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • AOSL Technology
  • STOK Health Care
  • Exchange
  • AOSL Nasdaq
  • STOK Nasdaq
  • Market Cap
  • AOSL 616.9M
  • STOK 638.8M
  • IPO Year
  • AOSL 2010
  • STOK 2019
  • Fundamental
  • Price
  • AOSL $26.55
  • STOK $11.67
  • Analyst Decision
  • AOSL Buy
  • STOK Strong Buy
  • Analyst Count
  • AOSL 3
  • STOK 5
  • Target Price
  • AOSL $32.33
  • STOK $24.50
  • AVG Volume (30 Days)
  • AOSL 340.2K
  • STOK 599.8K
  • Earning Date
  • AOSL 08-06-2025
  • STOK 08-06-2025
  • Dividend Yield
  • AOSL N/A
  • STOK N/A
  • EPS Growth
  • AOSL N/A
  • STOK N/A
  • EPS
  • AOSL N/A
  • STOK 0.88
  • Revenue
  • AOSL $680,974,000.00
  • STOK $190,908,000.00
  • Revenue This Year
  • AOSL $7.05
  • STOK $378.84
  • Revenue Next Year
  • AOSL $2.54
  • STOK N/A
  • P/E Ratio
  • AOSL N/A
  • STOK $13.31
  • Revenue Growth
  • AOSL 3.57
  • STOK 2333.81
  • 52 Week Low
  • AOSL $15.90
  • STOK $5.35
  • 52 Week High
  • AOSL $53.29
  • STOK $16.15
  • Technical
  • Relative Strength Index (RSI)
  • AOSL 67.18
  • STOK 59.02
  • Support Level
  • AOSL $23.54
  • STOK $11.17
  • Resistance Level
  • AOSL $24.87
  • STOK $12.13
  • Average True Range (ATR)
  • AOSL 1.15
  • STOK 0.50
  • MACD
  • AOSL 0.16
  • STOK -0.09
  • Stochastic Oscillator
  • AOSL 91.12
  • STOK 25.93

About AOSL Alpha and Omega Semiconductor Limited

Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: